Biodexa Pharmaceuticals (BDRX) Net Cash Flow (2013 - 2022)
Biodexa Pharmaceuticals (BDRX) reported Net Cash Flow of -$111428.2 for Q4 2022, up 63.75% on a YoY basis from -$68049.8 in Q4 2021, and up 5.16% sequentially from -$117489.0 in Q3 2022.
Biodexa Pharmaceuticals (BDRX) Net Cash Flow (2013 - 2022) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 10 years of Net Cash Flow data on file, last reported at -$111428.2 in Q4 2022.
- For the quarter ending Q4 2022, Net Cash Flow rose 63.75% year-over-year to -$111428.2; the trailing twelve-month figure through Dec 2025 stood at -$0.0 (changed 0.0% YoY), and the FY2025 full-year result was $9.1 million, up 263.93% from the prior year.
- Net Cash Flow rose to -$111428.2 in Q4 2022, from -$117489.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $8.6 million in Q4 2019 to a low of -$9.0 million in Q4 2020.
- A 5-year average of -$1.8 million and a median of -$212417.7 in 2021 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 95722.48% in 2019 and plunged 204.11% in 2020, its largest moves.
- Tracing BDRX's Net Cash Flow over 5 years: stood at -$9007.4 in 2018, then jumped by 95722.48% to $8.6 million in 2019, then sank by 204.11% to -$9.0 million in 2020, then jumped by 96.57% to -$307346.4 in 2021, then surged by 63.75% to -$111428.2 in 2022.
- Business Quant data shows BDRX's Net Cash Flow at -$111428.2 in Q4 2022, -$117489.0 in Q3 2022, and -$307346.4 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -111,428.19 |
| Dec 31, 2022 | -111,428.19 |
| Sep 14, 2022 | -117,488.97 |
| Sep 14, 2022 | -117,488.97 |
| Dec 31, 2021 | -307,346.42 |
| Dec 31, 2021 | -307,346.42 |
| Sep 17, 2021 | -4.64 Mn |
| Sep 17, 2021 | -4.64 Mn |
| Dec 31, 2020 | -8.97 Mn |
| Dec 31, 2020 | -8.97 Mn |
| Sep 10, 2020 | -8.55 Mn |
| Sep 10, 2020 | -8.55 Mn |
| Dec 31, 2019 | 8.61 Mn |
| Dec 31, 2019 | 8.61 Mn |
| Dec 31, 2018 | -9,007.37 |
| Dec 31, 2018 | -9,007.37 |
| Dec 31, 2017 | 45,140.60 |
| Dec 31, 2017 | 45,140.60 |
| Dec 31, 2016 | -16.28 Mn |
| Dec 31, 2016 | -16.28 Mn |